Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
| Metric | ABBV | CVS |
|---|
| Close | 264.02 | 90.27 |
| Market Cap | $464B | $117B |
| 1M | +1.97% | −4.89% |
| P/E (TTM) | 73.7 | 24.4 |
| Forward P/E | 16.8 | 13.2 |
| P/E 5-Yr Percentile | 51 | 65 |
| P/S | 7.2 | 0.3 |
| P/B | — | 1.5 |
| Dividend Yield | 4.47% | 3.49% |
| Latest Quarter Revenue | $17.0B | $106B |
| Revenue YoY | +10.2% | +7.3% |
| Gross Margin | 74.7% | 44.5% |
| Latest Quarter EPS | 2.03 | 2.31 |
| Avg Post-Earnings Move | ±1.7% | ±2.3% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.91% |
| 90-Day Net Insider Buying | −$8.2M | — |
ABBV · Revenue, Last 8 Quarters ($B)
CVS · Revenue, Last 8 Quarters ($B)
